| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0018 | 1 |